Chicago Says Drug Cos. Shouldn't Exit Opioid Bellwether Suit
Johnson & Johnson and Teva Pharmaceuticals can't escape a Chicago bellwether case over their allegedly deceptive opioid marketing because earlier rulings have already largely upheld the allegations, the city argued Monday....To view the full article, register now.
Already a subscriber? Click here to view full article